effect
compulsory
licensing
innovation
access
health
care
richard
past
fifteen
year
substantial
change
occurred
legal
regime
many
developing
country
respect
intellectual
property
right
moreover
beginning
january
agreement
aspect
ahnistered
world
trade
organization
became
standard
protecting
nation
seeking
engage
international
enhance
prospect
economic
growth
heretofore
ignored
subsequently
adopted
law
least
provide
basic
protection
innovator
outlined
represents
focus
including
brazil
china
jordan
korea
mexico
russia
approach
based
part
research
demonstrating
perceived
cost
associated
designing
implementing
enforcing
mechanism
low
light
long-term
benefit
certain
term
increased
investment
spite
positive
global
development
experience
government
official
either
failed
support
stronger
attempted
weaken
practice
widespread
use
bombarded
misinformation
public
defender
concerned
inhibit
local
businessmen
reacting
short-run
adapting
new
scheme
require
third
party
licence
technology
often
non-market-based
senior
vice
president
national
associate
inc
washmgton
federation
pharmaceutical
manufacturer
association
geneva
switzerland
provided
project
george
korenko
matthew
milner
renee
rainey
valuable
assistance
preparing
see
example
rapp
rozek
maskus
allowing
parallel
another
way
weakening
destroying
sunlcient
note
present
major
problem
industry
product
research-based
firm
currently
estimated
approximately
bdhon
annually
pkoul
et
al
developed
introduced
chemical
petroleum
machinery
fabricated
metal
primary
electrical
equipment
instrument
office
motor
vehicle
rubber
texnles
source
edwin
mansfield
patent
empirical
study
management
science
vol
february
pre-determined
royalty
rate
forcing
license
patented
rarely
ever
realize
market
value
endorses
neither
broad-based
adjunct
lscriminatory
treatment
matter
fact
potentially
harmfd
consequence
imposing
detrimental
ability
develop
citizen
policy
used
however
impact
especially
readily
apparent
given
high
up-front
ease
commercial
quantity
produced
stuhes
shown
particularly
important
according
strong
substantially
encouraging
eleven
studied
specifically
majority
would
available
consumer
without
table
perhaps
unintentionally
reduces
incentive
conduct
directed
creating
improved
medcines
introduce
existing
may
also
create
regulating
quality
licensed
gathering
data
adverse
event
recall
disseminating
information
proper
ensuring
actually
patient
contrary
view
opponent
impedes
reducing
invest
provides
framework
follow
protect
adopt
additional
constraint
innovative
demonstrated
need
modifj
delay
treat
discriminatory
manner
competitive
arise
targeted
remedy
consistent
protected
providmg
challenge
explore
strategy
possibly
expand
beyond
boundary
accept
ultimately
effort
opposing
viewed
voluntary
efficient
mean
transfer
technologes
within
system
protects
result
negotiation
willing
licensor
licensee
absent
well-defined
forced
enter
participate
voluntarily
bargaining
price
generally
market-place
multiple
candidate
potential
clinical
regulatory
marketing
expertise
commercialize
hand
choose
among
offering
alternative
negotiate
acquire
greatest
position
requisite
consider
across
therapeutic
category
force
fiat
determine
possible
role
enforce
resulting
contract
includmg
adequate
antitrust
undermines
already
programme
place
whereby
make
selected
thus
whch
addtional
regard
maintaining
assessing
organized
follows
section
explores
fallacy
regarding
address
summarizes
express
concern
fear
four
rise
decline
inhibited
increase
none
supported
evidence
dscuss
detail
actual
common
considering
higher
wdl
reasoning
misconception
monopoly
power
manifested
charging
hgher
essential
medication
exclusivity-not
grant
exclusive
sell
embodying
limited
period
time
competition
exists
non-patented
forty
blood
pressure
hypertension
united
state
even
antihypertensive
drug
receives
merely
hoen
holder
exclusivity
twenty
filing
hypertensive
toehold
entry
exerts
general
seller
ofpatented
necessarily
enjoy
raise
berkowitz
studed
level
movement
six
nine
five
prior
found
real
nominal
opposed
cite
enacting
strengthening
significant
strengthened
regulation
provision
buying
factor
contribute
bring
outcome
approve
timely
encourage
fiom
therapy
maintain
case
take
several
launched
transition
time-line
extent
pipeline
subject
determined
non-discriminatory
early
stage
legdative
process
procurement
timing
differ
gwes
differential
county
hfferent
environment
company
recover
sunk
using
price-control
welfare
incur
review
application
sample
initially
length
entrant
compete
originator
falling
wikerson
group
two
inhibitor
calcium
antagonist
contain
italy
slower
enacted
pharmaceuhcal
production
distribution
tax
tariff
due
dfierences
income
danzon
raised
likely
cause
number
correspondmg
decrease
overall
viability
allegedly
able
survive
wait
expires
copy
afforded
issue
adjust
rule
stimulate
multinational
devote
resource
emerge
providing
opportunity
long
hstory
respecting
generic
viable
growing
consisting
hundred
producer
additionally
mylan
duramed
done
usually
allow
dlsclosure
filed
created
supply
imitate
expire
employment
better
following
passage
covering
grew
faster
nationally
addtion
spending
italian
percent
whereas
virtually
unchanged
itahan
ranking
top
one
world-wide
zero
seven
experienced
spendmg
argentina
laggard
largest
latin
america
run
improving
india
produce
bonus
much
per
enhanced
inflow
foreign
direct
attract
research-oriented
job
applicant
scientist
educated
edehan
id
estimate
pirated
million
foundation
return
home
south
korean
student
received
degree
engmeering
university
planned
remain
graduation
recipient
intented
stay
acknowledged
trend
similar
exist
taiwan
contrast
earning
engineering
argentine
completing
begin
locating
geographic
area
form
core
human
capital
attracts
biotechnology
exhibited
pattern
canada
medical
bdl
repealed
earlier
legislation
people
upgraded
operated
plant
generated
june
july
doctoral
recipienfijotn
plan
byjeld
regioncountry
origin
indicator
zucker
october
brazilian
issued
ahnistrative
decree
sector
emergency
interest
never
implemented
indirect
export
glaxo
pfizer
building
expandmg
facility
shutting
yet
merck
conducted
trial
crixivanm
protease
rather
reason
mercks
decision
attracting
qualified
employee
manage
difficult
worker
politician
ranbaxy
indian
in&a
historically
overcome
negative
&scourages
seek
earn
profit
outside
european
established
profitable
business
one-half
revenue
consistently
ranbaxys
road
success
took
twenty-five
encouraged
could
sale
base
fund
manager
inma
hire
illustrates
facihtate
slowly
toward
throughout
population
severe
epidemic
contributing
incorrect
suggest
examined
solely
related
barrier
primarily
responsible
include
military
social
political
condition
online
bartlett
ghoshal
tully
financial
hurdle
physical
damaging
asymmetry
good
service
representative
non-governmental
model
list
le
improve
medicine
pursuing
obtain
avadable
prescribing
ineffective
wasteful
harmful
poor
counterfeit
constitute
continuing
hazard
illustrate
antibiotic
clarithromycin
broad-spectrum
proven
effective
variety
upper
lower
respiratory
tract
infection
brand
sold
abbott
laboratory
name
recent
version
asia
met
combined
criterion
acceptable
content
dissolution
impurity
applied
equivalent
must
guarantee
high-quality
goal
achieved
dlstribute
physician
pharmacist
payer
safeguard
reputation
adhering
manufacturing
cannot
copying
lack
free-ride
made
quahty
control
scholtz
ibid
nightingale
apply
fonvard-looking
focused
stimulating
sufficient
justifjr
selling
expect
receive
disease
specific
region
lanjouw
cockburn
malaria
markedly
mid-
since
introducing
indication
somehow
easier
hard
avoid
conclusion
historical
absence
played
retarding
diseasel
numerous
dlseases
affecting
rtfi
valley
fever
dracunculiasis
ebola
hemorrhagic
afiican
trypanosomiasis
chaga
american
type
searching
vaccine
prevent
cure
reduce
severity
symptom
troublesome
glennerster
kremer
recently
pointed
bargain-
fully
cover
bargain-down
arbiter
regulator
sole
purchaser
penny
dose
newer
priced
dollar
reach
poorest
developer
reluctant
expensive
risky
needed
commitment
purchase
therefore
sufficiently
credible
assure
renege
reflects
distortion
single
buyer
monopsony
depress
supplying
later
want
exported
response
inefficient
informational
ethnic
unrelated
safe
dnnlung
water
sanitation
greater
increasing
life
expectancy
reduced
reluctance
whether
first
reported
hungary
egypt
turkey
second
dramatic
three
march
respectively
analysis
show
limit
creates
claim
domestic
earned
depriving
community
prerequisite
dalton
serapio
remains
contemplating
location
emerging
weak
infrastructure
turbulence
instability
rnarkets
analysed
eventually
appears
necessary
concluded
strength
weakness
seems
high-technology
kind
transferred
get
older
statistically
relationship
ten-point
xu
chiang
impediment
fjess-developed
diffusion
importance
ministry
tourism
predicted
grow
announced
billion
facihties
april
neighbouring
lagged
behind
losing
stabihty
anticipation
put
compliance
help
restore
delayed
obligation
original
set
back
schedule
loss
benefited
passed
bill
legislative
action
doubled
different
measure
pazderka
eliminated
estevez
ed
mission
union
newsletter
resolved
harvey
bale
phamaceutical
sidintorgnewglobalizationpapersbalep#i
monitored
board
percentage
share
rose
stimulates
activity
world-class
suggesting
emergence
obtained
exponential
temporary
pro-competitive
long-
dsclosure
stimulated
knowledge
disclosure
explain
afier
uniformly
fded
adequately
well
known
douglas
ginsburg
stated
investment-inhibiting
hture
possibility
trademark
enxted
competitor
prove
quite
ginsberg
noted
basis
presuming
lost
lois
boland
diminishes
critical
component
technological
progess
undermine
find
unmet
medlcal
prolong
sdering
unknown
tool
urhkely
today
exception
conveyed
article
condltions
described
exceptional
conflict
unreasonable
normal
legitimate
unreasonably
prejudiced
shall
enjoyable
dlscrimination
invention
field
imported
locally
existed
zealand
authorization
involuntary
fall
identifies
respected-including
owner
payment
compensation
judicial
re~iew~
extreme
urgency
non-commercial
anti-competitive
dependent
sum
considered
intended
proposal
feature
misinterpret
message
contained
limitation
followed
define
situation
explicitly
circumventing
intent
comprehensive
required
presumption
maintained
two-stage
screening
identifj
act
gorlin
ofprotecting
correa
pp
considerable
sigmficance
compared
entitled
cross-licence
non-assignable
except
assignment
authority
case-by-case
objective
significance
claimed
rule-of-reason
adopting
infiastructures
identify
solve
specify
behaviour
department
justice
federal
commission
horizontal
merger
guideline
methodology
conducting
explicit
widely
acknowledge
dissemination
commercialization
establishing
enforceable
creaton
useful
work
expression
although
confer
exclude
question
close
substitute
exercise
eg
enable
superior
acumen
historic
accident
violate
effectively
enacts
choice
appear
antiulcerants
antihypertensives-calcium
inhibitors-broad
sh
spectrum
penicillin
non-narcotic
analgesic
anti-depressants
observe
molecule
theoretical
oversimplification
supreme
court
abuse
involved
ordered
case-
by-case
balto
mongoven
antiulceran
t
broad
antidepressant
overstate
combination
composed
kchard
ruth
ejects
raising
countnes
vakerics
always
nature
divestiture
continued
oversight
ensure
effectiveness
invoked
circumstance
threatened
xerox
corporation
entered
consent
agreed
machine
exceed
copier
settled
relating
plain
paper
price-discriminated
far
every
imaginable
&d
patenting
alone
requiring
collection
adrmnistrative
judge
bordons
unprecedented
removed
appeal
full
confirm
mere
insufficient
conclude
connection
prospective
withdrawing
ltd
sandoz
merged
novartis
identified
gene-therapy
affected
gene
felt
entity
posse
leadership
complete
transaction
non-
prducts~
relief
rare
chosen
abandon
bresnahan
scherer
ross
ofwhere
roche
holding
corange
baxter
immunex
solving
specified
undertook
isolated
signal
unrestricted
investigation
challenged
agency
order
obtaining
context
partner
approving
approved
open
propose
litigate
violates
imposed
rememes
conmtion
conhtions
bathroom
tissue
lutchen
towel
ten
upheld
proprietary
circuit
unlawfully
extend
unlawfil
reached
technical
dornier
lithotripters
device
break
kidney
stone
recognizes
initiated
final
report
advisorj
committee
workload
statistic
division
awwusdojgova
compiled
option
line
approval
re
fndependenent
sewice
organirutionr
antitmi
litigation
fed
cir
sewices
syrtems
no
theory
tends
undervalue
replacing
harold
varmus
director
institute
wrote
undermining
private
believe
unnecessarily
jeopardize
failure
declined
implementation
grown
extremely
canadian
unable
rendered
suggests
average
point
annual
index
corresponding
canahan
foregone
unlawful
particular
product-market
expend
emphasizing
eastman
observed
administering
selective
determining
eligibility
reimbursement
coverage
pharmicare
adjustment
li~ensing~
discussed
undated
finkelstein
bittingcr
apotex
arms-length
allows
efficiently
enforcement
indicated
discretion
chilbng
arrangement
likewise
accepts
facilitates
broader
addltional
advantageous
natural
occurrence
disadvantage
undervaluing
destroys
perceive
presume
recognize
combine
complementary
tangible
intangible
asset
enables
supra-
impose
otherssl
dlfficult
gain
relinquish
suffer
denied
discovered
inhibits
ratio
informative
anand
khanna
valentine
draft
advertising
persuasive
doctor
unnecessary
eventual
costly
afiica
suffering
permit
copied
aid
stopping
spread
treating
afflicted
attention
proponent
alleviate
africa
addressed
end
abihty
complex
fair
producing
monitor
educate
provider
us
purchased
supplied
higher-priced
pay
material
testing
reagent
wellcome
squibb
boehringer
ingelheim
bank
signed
joint
statement
aimed
accelerating
getting
high-
industry-sponsored
addressing
botswana
partnership
collaborative
involving
melinda
gate
republic
memcines
offered
give
away
diflucanm
brain
prevalent
afi-ica
threat
african
life-saving
frequently
deprives
discourages
future
crisis
tuberculosis
solved
discover
solution
scientific
fachtate
finding
co-operation
flow
cost-effective
co-operate
preferential
ahra
program
relier
achieve
secure
muck
co
launch
hw
initiative
donation
malarone
task
child
survival
rh
capability
appropriate
quality-control
importantly
disseminate
participating
preventing
sleeping
sickness
vitamin
deficiency
trachona
river
blindness
leprosy
lymphatic
fdariasis
leishmaniosis
cholera
fundamental
hseases
progress
requires
discovering
dsseminating
fundmg
helpful
largely
unfounded
upon
scrutiny
alleged
non-existent
unemployment
envisioned
inherent
prophylactic
description
various
anti-retroviral
prompted
namibia
offer
loan
shangula
inhibiting
current
&scouraging
delaying
long-run
harm
successful
whle
assurance
vigourously
alliance
productive
requirement
afnca
relies
pink
sheet
bharat
tarun
structure
journal
industrial
expanding
economics
consulate
sydney
australia
david
james
food
barlett
christopher
surnantra
going
lesson
late
mover
harvard
talking
meeting
mwwhaiweborgcampaignclscholtzr
timothy
confainment
backgroundersimpacts-cost-price-controls
dracunculiusis
guinea
worm
diseuse
medium
relation
center
prevention
idem
parasitic
mww
cdc
govncidpdparasites
viral
ajiicans
carlos
optionsfor
donald
manuel
jr
globalizing
commerce
administration
september
patricia
pharmacoeconomics
advisory
revision
efiiencies
apnl
guidelinesfor
ipguide
congress
fiscal
annualreportpd
inquiry
toronto
ontario
december
edelman
margalit
tango
step
brief
juan
news
curried
combat
august
stan
peter
bittinger
competitiveness
preliminary
look
sloan
school
uncertainty
academy
rachel
michael
brooking
institution
washington
jacques
~haumaceutica~-~elated
london
ajoint
oflntent
independent
antitrwst
jean
iain
cockbum
aftr
bureau
cambridge
massachusetts
working
finance
discussion
keith
economy
dfision
calgary
press
bulgary
cheap
york
recipientsjom
byfield
oforigin
regionlcountry
jump
costa
rica
survey
productsjom
bohumir
pecoul
bernard
pierre
chirac
patrice
trouiller
pinel
drwgs
battle
joumal
november
eleventh
ending
ottawa
&chard
nicola
frederick
stephen
strwcture
performance
edition
houghton
mifflin
boston
perspective
pricing
kalumbi
afican
leader
misguided
turning
wer
fight
post
biltl
hrv
release
ellen
statementom
mdecins
sans
campaign
update
fission
key
speech
delivered
brussels
belgium
speaker
text
database
image
thomas
debra
dominance
intel
israel
conference
tel
aviv
speechesotherdvisraelin
varrnus
letterjom
vamus
robert
weissman
bethesda
maryland
wilkerson
decreasing
excllrrivity
bin
eric
florida
patentp&
lynne
michal
darby
marilynn
brewer
birth
entetprises